, Tracking Stock Market Picks
Enter Symbol:
Amarin Corporation Plc (AMRN) [hlAlert]

up 33.12 %

Amarin Corporation Plc (AMRN) upgraded to Buy with price target $2.50 by Citigroup

Posted on: Friday,  Nov 8, 2013  8:25 AM ET by Citigroup

Citigroup rated Buy Amarin Corporation Plc (NASDAQ: AMRN) on 11/08/2013, when the stock price was $1.57. Since
then, Amarin Corporation Plc has gained 33.12% as of 09/08/2015's recent price of $2.09.
If you would have followed this Citigroup's recommendation on AMRN, you would have gained 33.12% of your investment in 669 days.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2013 8:25 AM Buy
1.57 2.50
as of 12/13/2013
1 Week down  -2.25 %
1 Month up  12.33 %
3 Months down  -59.81 %
1 YTD down  -65.33 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/18/2013 8:25 AM Hold
11/27/2012 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy